Immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis: a network meta‐analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Immunomodulators and Immunosuppressants for Relapsing‐remitting Multiple Sclerosis: a Network Meta‐analysis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433778/0/Celecoxib_for_rheumatoid_arthritis:_Cochrane_systematic_review. Accessed 28 March 2024.
Immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis: a network meta‐analysis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433778/0/Celecoxib_for_rheumatoid_arthritis:_Cochrane_systematic_review. Accessed March 28, 2024.
Immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis: a network meta‐analysis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433778/0/Celecoxib_for_rheumatoid_arthritis:_Cochrane_systematic_review
Immunomodulators and Immunosuppressants for Relapsing‐remitting Multiple Sclerosis: a Network Meta‐analysis [Internet]. In: Cochrane Abstracts. [cited 2024 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433778/0/Celecoxib_for_rheumatoid_arthritis:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis: a network meta‐analysis
ID - 433778
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433778/0/Celecoxib_for_rheumatoid_arthritis:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -